The Full Wiki

More info on PHF3

PHF3: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

PHD finger protein 3

PDB rendering based on 2dme.
Available structures
Symbols PHF3; KIAA0244; MGC142210; MGC142212
External IDs OMIM607789 MGI2446126 HomoloGene9040 GeneCards: PHF3 Gene
RNA expression pattern
PBB GE PHF3 215718 s at tn.png
PBB GE PHF3 217951 s at tn.png
PBB GE PHF3 217952 x at tn.png
More reference expression data
Species Human Mouse
Entrez 23469 213109
Ensembl ENSG00000118482 ENSMUSG00000048874
UniProt Q92576 n/a
RefSeq (mRNA) NM_015153 XM_129836
RefSeq (protein) NP_055968 XP_129836
Location (UCSC) Chr 6:
64.4 - 64.48 Mb
Chr 1:
30.75 - 30.82 Mb
PubMed search [1] [2]

PHD finger protein 3 is a protein that in humans is encoded by the PHF3 gene.[1][2]


  1. ^ Fischer U, Struss AK, Hemmer D, Michel A, Henn W, Steudel WI, Meese E (Mar 2002). "PHF3 expression is frequently reduced in glioma". Cytogenet Cell Genet 94 (3-4): 131-6. PMID 11856869.  
  2. ^ "Entrez Gene: PHF3 PHD finger protein 3".  

Further reading

  • Nakajima D, Okazaki N, Yamakawa H, et al. (2003). "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.". DNA Res. 9 (3): 99–106. doi:10.1093/dnares/9.3.99. PMID 12168954.  
  • Nagase T, Seki N, Ishikawa K, et al. (1997). "Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.". DNA Res. 3 (5): 321–9, 341–54. doi:10.1093/dnares/3.5.321. PMID 9039502.  
  • Struss AK, Romeike BF, Munnia A, et al. (2001). "PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.". Oncogene 20 (31): 4107–14. doi:10.1038/sj.onc.1204552. PMID 11464277.  
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.  
  • Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805–11. doi:10.1038/nature02055. PMID 14574404.  
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.  
  • Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMID 15302935.  
  • Ballif BA, Villén J, Beausoleil SA, et al. (2005). "Phosphoproteomic analysis of the developing mouse brain.". Mol. Cell Proteomics 3 (11): 1093–101. doi:10.1074/mcp.M400085-MCP200. PMID 15345747.  
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.  
  • Pallasch CP, Struss AK, Munnia A, et al. (2005). "Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.". Int. J. Cancer 117 (3): 456–9. doi:10.1002/ijc.20929. PMID 15906353.  
  • Beausoleil SA, Villén J, Gerber SA, et al. (2006). "A probability-based approach for high-throughput protein phosphorylation analysis and site localization.". Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.  
  • Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.  

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.



Got something to say? Make a comment.
Your name
Your email address